Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – When gynecologic surgery is performed laparoscopically, the occurrence of thromboembolism is quite rare, even in patients with gynecologic malignancy, researchers report in the…
NEW YORK (Reuters Health) – General surgery patients with elevated blood glucose levels after the operation have an increased risk of developing an infection at the surgical site,…
NEW YORK (Reuters Health) – The problem of drooling in children with neurological disorders can be relieved in about half of cases by injections of botulinum toxin into…
NEW YORK (Reuters Health) – The tyrosine-kinase inhibitor pazopanib seems to be a promising option for treating progressive metastatic differentiated thyroid cancer that is unresponsive to radioiodine therapy,…
NEW YORK (Reuters Health) – Delivery of abciximab directly to the intracoronary thrombus in patients with acute coronary syndromes is more effective than intracoronary bolus infusion in reducing…
NEW YORK (Reuters Health) – Rates of deep vein thrombosis (DVT) in immobilized stroke patients are lower when thigh-length graduated compression stockings are used rather than below-knee stockings,…
NEW YORK (Reuters Health) – In children hospitalized with Henoch-Schönlein purpura, or HSP, corticosteroid treatment is associated with a decreased likelihood of several clinically relevant outcomes, according to…
NEW YORK (Reuters Health) – Response rates are higher when bortezomib plus dexamethasone rather than vincristine plus doxorubicin plus dexamethasone (VAD) is used as induction therapy before stem-cell…
NEW YORK (Reuters Health) – Using the rapid-acting insulin analog glulisine instead of regular human insulin at mealtimes improves glycemic control in hospitalized patients with type 2 diabetes,…
NEW YORK (Reuters Health) – The concern about proton pump inhibitors (PPIs) possibly interfering with the efficacy of clopidogrel may be misdirected, according to a new report. It…
